[go: up one dir, main page]

ES2040629B1 - Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos. - Google Patents

Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos.

Info

Publication number
ES2040629B1
ES2040629B1 ES09102818A ES9102818A ES2040629B1 ES 2040629 B1 ES2040629 B1 ES 2040629B1 ES 09102818 A ES09102818 A ES 09102818A ES 9102818 A ES9102818 A ES 9102818A ES 2040629 B1 ES2040629 B1 ES 2040629B1
Authority
ES
Spain
Prior art keywords
alq
benzotiazepine
trycyclic
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09102818A
Other languages
English (en)
Other versions
ES2040629A1 (es
Inventor
Noverola Salvador Vega
Martin Juan Antonio Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
ADIR SARL
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, ADIR SARL filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES09102818A priority Critical patent/ES2040629B1/es
Priority to EP92203913A priority patent/EP0547705A1/en
Priority to ZA929777A priority patent/ZA929777B/xx
Priority to CA002085705A priority patent/CA2085705A1/en
Priority to JP4338491A priority patent/JPH061794A/ja
Priority to AU30303/92A priority patent/AU3030392A/en
Publication of ES2040629A1 publication Critical patent/ES2040629A1/es
Application granted granted Critical
Publication of ES2040629B1 publication Critical patent/ES2040629B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS TRICICLICOS DE LA BENZOTIAZEPINA FARMACOLOGICAMENTE ACTIVOS. COMPRENDE, EN OTRAS TRANSFORMACIONES: (I) REACCION DE (I) EN QUE R3=H Y R4=OHM, SH O NH2 CON ALQ NR4 R6 PARA DAR (I) EN QUE RS3=H Y R3=O ALQ NR5 R6, S-ALQ NR5 R6 O HN-ALQ- NR5 R6; (II) REACCION DE (I) EN QUE R3=H Y R4=W CON HO-ALQ-NR4 R6, HS-ALQ-NR5 R6 O H2N-ALQ-NR5 R6 PARA DAR (I) EN QUE R3=H Y R4=O-ALQ-NR5 R6, -S-ALQ-NR5 R6 O HN-ALQ-NR5 R6; (III) REACCION DE (I) EN QUE R3=H Y RS4=OH CON HO-ALQ-W PARA DAR (I) EN QUE R3=H Y R4=O-ALQ-NR5 R6; (IV) REACCION DE (I) EN QUE R3 Y R4 JUNTOS REPRESENTAN =N-OBS -SCABS+SC CON W-ALQ-NR4 R6. W REPRESENTA UN GRUPO REACTIVO. LOS RESTANTES SIMBOLOS DE (I) REPRESENTAN DIFERENTES RADICALESORGANICOS. APLICACION COMO AGENTES PSICOTROPICOS. **FORMULA**
ES09102818A 1991-12-18 1991-12-18 Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos. Expired - Fee Related ES2040629B1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES09102818A ES2040629B1 (es) 1991-12-18 1991-12-18 Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos.
EP92203913A EP0547705A1 (en) 1991-12-18 1992-12-15 Pharmacologically active tricyclic benzotriazepine derivatives
ZA929777A ZA929777B (en) 1991-12-18 1992-12-17 Pharmacologically active tricyclic derivatives
CA002085705A CA2085705A1 (en) 1991-12-18 1992-12-17 Pharmacologically active tricyclic derivatives
JP4338491A JPH061794A (ja) 1991-12-18 1992-12-18 薬理的に活性な三環誘導体
AU30303/92A AU3030392A (en) 1991-12-18 1992-12-18 Pharmacologically active tricyclic derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09102818A ES2040629B1 (es) 1991-12-18 1991-12-18 Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos.

Publications (2)

Publication Number Publication Date
ES2040629A1 ES2040629A1 (es) 1993-10-16
ES2040629B1 true ES2040629B1 (es) 1994-06-16

Family

ID=8274534

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09102818A Expired - Fee Related ES2040629B1 (es) 1991-12-18 1991-12-18 Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos.

Country Status (6)

Country Link
EP (1) EP0547705A1 (es)
JP (1) JPH061794A (es)
AU (1) AU3030392A (es)
CA (1) CA2085705A1 (es)
ES (1) ES2040629B1 (es)
ZA (1) ZA929777B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3290664B2 (ja) * 1993-12-28 2002-06-10 明治製菓株式会社 ３環性ベンゾアゼピンおよびベンゾチアゼピン誘導体
KR100286494B1 (ko) * 1995-06-15 2001-04-16 이치로 키타사토 삼환성벤즈아제핀화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594827B1 (fr) * 1986-02-21 1988-05-20 Adir Nouveau derive tricyclique denomme acide ((chloro-3 methyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazepine (1,2) yl-11 amino)-5 pentazoique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
US4803197A (en) * 1987-01-12 1989-02-07 Ciba-Geigy Corporation 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives
ES2021548A6 (es) * 1990-06-07 1991-11-01 Consejo Superior Investigacion Procedimiento de obtencion de nuevas trioxo-tieno-(2,1) benzotiazepinas.

Also Published As

Publication number Publication date
ZA929777B (en) 1993-06-23
JPH061794A (ja) 1994-01-11
EP0547705A1 (en) 1993-06-23
ES2040629A1 (es) 1993-10-16
CA2085705A1 (en) 1993-06-19
AU3030392A (en) 1993-06-24

Similar Documents

Publication Publication Date Title
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
ES2140961T3 (es) Nuevos derivados de 19-nor-pregneno.
MX9700249A (es) Compuestos ariltios como agentes antibacteriales yantivirales.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
CU22869A3 (es) 1-aril-pirazoles plaguicidas
ES2138622T3 (es) Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
ES2062634T3 (es) Composicion con liberacion controlada del farmaco.
ES2171428T3 (es) Derivados de galantamina, un procedimiento para su preparacion y su uso como medicamentos.
ES2065755T3 (es) Derivados de 3-aminopiridacinas activos sobre el sistema nervioso central.
NO20005793L (no) Sammensetninger som inneholder organisk mono- eller dinitrat for behandling av impotens
ES2101073T3 (es) Nuevos aza-androstano-derivados 17-beta-substituidos.
MX9100607A (es) Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES2038667T5 (es) Un derivado de carbamato de yodopropargilo, un metodo para su produccion y composiciones fungicidas que lo contienen como ingrediente activo.
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
ES2059931T3 (es) Procedimiento para el tratamiento de la hipertrofia e hiperplasia cardiaca asi como vascular.
AR009120A1 (es) Una composicion de grasa de urea y mecanismos que contienen tal composicion
ES2040629B1 (es) Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2100396T3 (es) Derivados de 17-(3-furil)- y 17-(4-piridazinil)-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que los contienen.
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
AR027578A1 (es) Derivados de indano
ES2179070T3 (es) Derivados del taxano c9 y composiciones farmaceuticas que las contienen.
UY24009A1 (es) Compuestos ariltio útiles como agentes antivirales y antibacteriales

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041220